Niclosamide topical - AntibioTx

Drug Profile

Niclosamide topical - AntibioTx

Alternative Names: ATx 201 - AntibioTx; ATx201

Latest Information Update: 07 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AntibioTx
  • Class Anthelmintics; Antibacterials
  • Mechanism of Action Nucleic acid nucleotide and nucleoside modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Atopic dermatitis
  • Phase I/II Eczema
  • Phase I Unspecified

Most Recent Events

  • 06 Nov 2017 AntibioTx completes a phase I trial in an Undefined indication (In volunteers) in USA (Topical) (NCT03301870)
  • 09 Oct 2017 AntibioTx plans a phase I trial in Healthy volunteers in USA (NCT03301870)
  • 04 Oct 2017 Phase-I clinical trials in an Undefined indication (In volunteers) in USA (Topical) (NCT03301870)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top